PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.00%
Negative revenue growth while NXPI stands at 5.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.56%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-0.77%
Negative EBIT growth while NXPI is at 170.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.89%
Negative operating income growth while NXPI is at 170.13%. Joel Greenblatt would press for urgent turnaround measures.
4.76%
Net income growth under 50% of NXPI's 169.25%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.90%
EPS growth under 50% of NXPI's 137.82%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.26%
Diluted EPS growth under 50% of NXPI's 140.27%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.82%
Share reduction while NXPI is at 13.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.77%
Reduced diluted shares while NXPI is at 12.24%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
11.84%
Dividend growth of 11.84% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
1.49%
Positive OCF growth while NXPI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-0.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
40.82%
10Y revenue/share CAGR above 1.5x NXPI's 13.78%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
4.85%
5Y revenue/share CAGR under 50% of NXPI's 86.10%. Michael Burry would suspect a significant competitive gap or product weakness.
17.82%
3Y revenue/share CAGR under 50% of NXPI's 36.66%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
149.80%
10Y OCF/share CAGR under 50% of NXPI's 869.19%. Michael Burry would worry about a persistent underperformance in cash creation.
34.74%
Below 50% of NXPI's 78.24%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
45.06%
3Y OCF/share CAGR at 75-90% of NXPI's 56.92%. Bill Ackman would press for improvements in margin or overhead to catch up.
102.44%
Below 50% of NXPI's 312.64%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
2.85%
Below 50% of NXPI's 885.56%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
248.52%
Below 50% of NXPI's 895.73%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
32.16%
Below 50% of NXPI's 918.47%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.44%
Below 50% of NXPI's 1013.74%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-0.13%
Negative 3Y equity/share growth while NXPI is at 942.42%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
1175.51%
Dividend/share CAGR of 1175.51% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
192.39%
Dividend/share CAGR of 192.39% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
80.78%
3Y dividend/share CAGR of 80.78% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-21.34%
Firm’s AR is declining while NXPI shows 71.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.52%
Inventory is declining while NXPI stands at 150.20%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.87%
Negative asset growth while NXPI invests at 219.44%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.58%
Under 50% of NXPI's 802.64%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.29%
We’re deleveraging while NXPI stands at 82.42%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.16%
Our R&D shrinks while NXPI invests at 78.65%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.68%
We cut SG&A while NXPI invests at 116.23%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.